1. Home
  2. RGEN vs FRT Comparison

RGEN vs FRT Comparison

Compare RGEN & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FRT
  • Stock Information
  • Founded
  • RGEN 1981
  • FRT 1962
  • Country
  • RGEN United States
  • FRT United States
  • Employees
  • RGEN N/A
  • FRT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FRT Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • FRT Real Estate
  • Exchange
  • RGEN Nasdaq
  • FRT Nasdaq
  • Market Cap
  • RGEN 7.6B
  • FRT 9.5B
  • IPO Year
  • RGEN N/A
  • FRT N/A
  • Fundamental
  • Price
  • RGEN $156.55
  • FRT $103.95
  • Analyst Decision
  • RGEN Buy
  • FRT Buy
  • Analyst Count
  • RGEN 12
  • FRT 16
  • Target Price
  • RGEN $187.44
  • FRT $122.19
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • FRT 603.4K
  • Earning Date
  • RGEN 02-19-2025
  • FRT 02-10-2025
  • Dividend Yield
  • RGEN N/A
  • FRT 4.25%
  • EPS Growth
  • RGEN N/A
  • FRT N/A
  • EPS
  • RGEN N/A
  • FRT 3.44
  • Revenue
  • RGEN $633,513,000.00
  • FRT $1,185,020,000.00
  • Revenue This Year
  • RGEN $2.28
  • FRT N/A
  • Revenue Next Year
  • RGEN $9.88
  • FRT $4.95
  • P/E Ratio
  • RGEN N/A
  • FRT $30.19
  • Revenue Growth
  • RGEN N/A
  • FRT 5.41
  • 52 Week Low
  • RGEN $113.50
  • FRT $95.98
  • 52 Week High
  • RGEN $211.13
  • FRT $118.34
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • FRT 33.41
  • Support Level
  • RGEN $149.15
  • FRT $101.33
  • Resistance Level
  • RGEN $160.64
  • FRT $112.29
  • Average True Range (ATR)
  • RGEN 5.96
  • FRT 1.89
  • MACD
  • RGEN 0.91
  • FRT -0.80
  • Stochastic Oscillator
  • RGEN 79.57
  • FRT 22.20

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

Share on Social Networks: